Literature DB >> 8884580

The treatment of congenital lactic acidoses.

A A Morris1, J V Leonard.   

Abstract

Congenital lactic acidoses form a heterogeneous group of disorders: this paper considers primarily defects of the pyruvate dehydrogenase complex and the respiratory chain. Attempts to treat these disorders are hampered by uncertainty concerning the pathophysiology and by the central role of the enzymes in cellular metabolism. Few strategies are of proven efficacy, though many have been tried, including dietary manipulation, enhancement of residual enzyme activity, artificial electron acceptors and free-radical scavengers. Evaluation of treatment is complicated by the rarity, heterogeneity and unpredictable course of the diseases. Double-blind placebo-controlled trials are needed.

Entities:  

Mesh:

Year:  1996        PMID: 8884580     DOI: 10.1007/bf01799117

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  43 in total

1.  MELAS syndrome with mitochondrial tRNA(Leu)(UUR) mutation: correlation of clinical state, nerve conduction, and muscle 31P magnetic resonance spectroscopy during treatment with nicotinamide and riboflavin.

Authors:  A M Penn; J W Lee; P Thuillier; M Wagner; K M Maclure; M R Menard; L D Hall; N G Kennaway
Journal:  Neurology       Date:  1992-11       Impact factor: 9.910

2.  31P NMR study of improvement in oxidative phosphorylation by vitamins K3 and C in a patient with a defect in electron transport at complex III in skeletal muscle.

Authors:  S Eleff; N G Kennaway; N R Buist; V M Darley-Usmar; R A Capaldi; W J Bank; B Chance
Journal:  Proc Natl Acad Sci U S A       Date:  1984-06       Impact factor: 11.205

3.  Variable clinical presentation in patients with defective E1 component of pyruvate dehydrogenase complex.

Authors:  B H Robinson; H MacMillan; R Petrova-Benedict; W G Sherwood
Journal:  J Pediatr       Date:  1987-10       Impact factor: 4.406

4.  Coenzyme Q in serum and muscle of 5 patients with Kearns-Sayre syndrome and 12 patients with ophthalmoplegia plus.

Authors:  S Zierz; G Jahns; F Jerusalem
Journal:  J Neurol       Date:  1989-02       Impact factor: 4.849

5.  Coenzyme Q10 with multiple vitamins is generally ineffective in treatment of mitochondrial disease.

Authors:  P M Matthews; B Ford; R J Dandurand; D H Eidelman; D O'Connor; A Sherwin; G Karpati; F Andermann; D L Arnold
Journal:  Neurology       Date:  1993-05       Impact factor: 9.910

6.  E1 pyruvate dehydrogenase deficiency in a child with motor neuropathy.

Authors:  G Bonne; C Benelli; L De Meirleir; W Lissens; M Chaussain; M Diry; J P Clot; G Ponsot; V Geoffroy; J P Leroux
Journal:  Pediatr Res       Date:  1993-03       Impact factor: 3.756

7.  Therapeutic effect of sodium dichloroacetate on visual and auditory hallucinations in a patient with MELAS.

Authors:  T Saijo; E Naito; M Ito; E Takeda; T Hashimoto; Y Kuroda
Journal:  Neuropediatrics       Date:  1991-08       Impact factor: 1.947

8.  Dilated cardiomyopathy due to type II X-linked 3-methylglutaconic aciduria: successful treatment with pantothenic acid.

Authors:  I Ostman-Smith; G Brown; A Johnson; J M Land
Journal:  Br Heart J       Date:  1994-10

9.  A mitochondrial myopathy in an infant with lactic acidosis.

Authors:  V Griebel; I Krägeloh-Mann; W Ruitenbeek; J M Trijbels; W Paulus
Journal:  Dev Med Child Neurol       Date:  1990-06       Impact factor: 5.449

10.  Investigation of human mitochondrial myopathies by phosphorus magnetic resonance spectroscopy.

Authors:  D L Arnold; D J Taylor; G K Radda
Journal:  Ann Neurol       Date:  1985-08       Impact factor: 10.422

View more
  5 in total

1.  Mitochondrial Disease.

Authors:  Roser Pons; Darryl C. De Vivo
Journal:  Curr Treat Options Neurol       Date:  2001-05       Impact factor: 3.598

2.  Biochemical monitoring of the treatment in paediatric patients with mitochondrial disease.

Authors:  R Artuch; M A Vilaseca; M Pineda
Journal:  J Inherit Metab Dis       Date:  1998-12       Impact factor: 4.982

Review 3.  Emergency management of inherited metabolic diseases.

Authors:  V Prietsch; M Lindner; J Zschocke; W L Nyhan; G F Hoffmann
Journal:  J Inherit Metab Dis       Date:  2002-11       Impact factor: 4.982

Review 4.  Potential therapeutic use of the ketogenic diet in autism spectrum disorders.

Authors:  Eleonora Napoli; Nadia Dueñas; Cecilia Giulivi
Journal:  Front Pediatr       Date:  2014-06-30       Impact factor: 3.418

5.  Mendeliome sequencing enables differential diagnosis and treatment of neonatal lactic acidosis.

Authors:  Walid Fazeli; Mert Karakaya; Peter Herkenrath; Anne Vierzig; Jörg Dötsch; Jürgen-Christoph von Kleist-Retzow; Sebahattin Cirak
Journal:  Mol Cell Pediatr       Date:  2016-06-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.